Developer docs
API playgroundTry for free, no card

Search company profiles

NMS Labs

Full company profile

uuid0002wpc

Namestring
NMS Labs
Legal namestring
NMS Labs
Websiteurl
nmslabs.com
Company typeenum
Private
Founded yearint
1975
Descriptiontext

NMS Labs is a privately-held bioanalytical toxicology laboratory headquartered in Horsham, Pennsylvania, founded around 1975 and operating for over 50 years. The company provides routine and esoteric toxicology testing services to law enforcement agencies, hospitals, medical examiners and coroners, crime laboratories, attorneys, correctional facilities, contract research organizations, and academic research institutions across the United States. Its service portfolio spans drug-impaired driving (DUID) toxicology, postmortem toxicology, drugs-of-abuse screening, novel psychoactive substances (NPS) testing, newborn umbilical cord tissue toxicology, exposure monitoring including PFAS biomonitoring, forensic drug chemistry, hemp/marijuana differentiation, therapeutic drug monitoring, and pharmaceutical testing.

The company's analytical platform is built on advanced mass spectrometry instrumentation — including GC/MS with derivatization, LC-MS/MS, ICP/MS, time-of-flight mass spectrometry, and proprietary immunoassays — supported by over 60 board-certified toxicologists and a continuously updated catalog of 2,500+ esoteric tests. Differentiated capabilities include the Comprehensive Umbilical Cord Drug Panel, hemp/marijuana differentiation methods recognized by the Texas Forensic Science Commission, dynamically updated NPS panels developed through the CFSRE partnership, and PFAS biomonitoring dating back to 2001. The lab holds a dense stack of accreditations (ABFT, ANAB ISO/IEC 17025, CAP ISO 15189, CLIA, FDA, DEA) and licenses across more than 15 state health departments.

NMS Labs generates revenue on a fee-for-service professional services model with monthly billing under net-30 terms for established accounts and pre-payment requirements for new or non-established accounts. Services are not offered directly to consumers — samples must be submitted by authorized professionals. Distribution is primarily through direct sales via dedicated phone/email lines by segment (Clinical & Research, Forensic, Expert Services, Crime Labs, Pharmaceutical Testing), supported by a client portal, an online test catalog of 2,500+ tests, and five physical laboratory locations across Pennsylvania, Texas, and North Carolina. The company also monetizes adjacent expertise through expert witness testimony, litigation support, and educational content development.

Short descriptiontext

NMS Labs is a privately-held bioanalytical toxicology laboratory offering over 2,500 esoteric toxicology tests — including postmortem, DUID, NPS, PFAS, and pharmaceutical testing — to law enforcement, medical examiners, hospitals, crime labs, CROs, and research institutions across five US laboratory locations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersHorsham, United States
HQ citystring
Horsham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
forensic toxicology testing, clinical toxicology services, postmortem toxicology analysis, drug chemistry testing, pharmaceutical laboratory services
Industry4 codes
1Toxicology & Therapeutic Drug Monitoring Laboratories
CodeHLAFAMAFPrimaryYes
2Reference & Esoteric Testing Laboratories
CodeHLAFAMAJPrimaryNo
3Bioanalytical & PK/PD Sample Analysis (Trial Support)
CodeHLAGAEAGPrimaryNo
4Bioanalytical Testing (PK/ADA/NAb)
CodeHLAGADAAPrimaryNo
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Testing Laboratories8734
Product category
Forensic and Clinical Toxicology Laboratory Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Laboratory Testing Services
TypeProfessional Services
Description

NMS Labs generates revenue through providing comprehensive toxicology and drug identification testing services to various customers including law enforcement agencies, hospitals, medical examiners, crime laboratories, attorneys, correctional facilities, contract research organizations, and government agencies. Services include forensic toxicology, clinical toxicology, drug chemistry, exposure monitoring, pharmaceutical testing, and expert witness testimony. Billing is conducted through established accounts billed monthly with net-30 terms, and pre-payment is required for non-established accounts or patient/party responsibility payments.

nmslabs.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Pricing details1 tier
1Laboratory Testing Services
ModelOtherBilling cadenceMonthly
Notes

NMS Labs does not publicly disclose specific pricing. Fees are subject to change. Established accounts are billed monthly by itemized statement with net 30-day terms. Pre-payment is required for non-established accounts, government agencies must submit official pre-numbered purchase orders. Medicaid, Medicare, or third-party billing services are not provided.

nmslabs.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

NMS Labs is a bioanalytical toxicology laboratory providing expansive routine and esoteric toxicology testing services to clinical, forensic, pharmaceutical, and research clients. Core offerings include forensic toxicology (postmortem, DUID, drug chemistry), clinical toxicology (drugs of abuse, therapeutic monitoring, newborn toxicology), exposure monitoring (PFAS biomonitoring), novel psychoactive substance testing, and pharmaceutical laboratory services. Supporting the testing services are expert witness consultation, expert testimony, and a client portal for sample submission and report retrieval.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 98.8% PFAS detection rate in human blood samples tested (10,566 samples)
+2 more records
Product overview1 text field

NMS Labs is a toxicology laboratory offering a comprehensive portfolio of testing services rather than a single unified product. The core offerings include Drug Impaired Driving (DUID) Testing, Drugs of Abuse Testing, Postmortem Toxicology (with Basic, Expanded, and NMS TotalTox panel tiers), Novel Psychoactive Substances (NPS) Testing, Drug Facilitated Crime Panel, Exposure Monitoring (including PFAS Human Blood Testing), Forensic Drug Chemistry, Newborn Toxicology using Umbilical Cord Tissue, Pharmaceutical Testing, THC/Hemp-Marijuana Differentiation, and Therapeutic Drug Monitoring. Supporting services include Expert Services (expert witness testimony and litigation support), Client Portal for online access, and specialized offerings like Wasp Dope Testing for correctional facilities. The company serves diverse segments including law enforcement, medical examiners, hospitals, crime laboratories, attorneys, researchers, and correctional facilities.

Product and service13 records
1Drug Impaired Driving (DUID) Testing
CategoryForensic Toxicology
Description

Toxicology testing services for drug-impaired driving cases, covering alcohol, illicit drugs, OTC drugs, prescription drugs, Delta-8/Delta-9 THC, and Novel Psychoactive Substances with chain of custody and litigation support. Targeted at law enforcement agencies and the criminal justice system.

2Drug Facilitated Crime Panel
CategoryForensic Toxicology
Description

Single panel testing for substances specific to drug-facilitated crime investigations, covering nearly 100 analytes including the most frequently detected substances in DFC cases. Used by law enforcement and attorneys handling drug-facilitated crime cases.

3Drugs of Abuse Testing
CategoryClinical and Forensic Toxicology
Description

Comprehensive testing for drugs of abuse including designer opioids, synthetic cannabinoids, bath salts, fentanyl analogues, hallucinogens, GHB, and prescription/OTC medications. Serves hospitals, correctional facilities, and law enforcement agencies.

4Expert Services
CategoryExpert Witness and Litigation Support
Description

Board-certified toxicologist consultation, expert witness testimony, affidavit preparation, litigation packages, and pre-trial services for medico-legal investigations. Supports attorneys, law enforcement, and medico-legal stakeholders.

5Exposure Monitoring
CategoryEnvironmental and Occupational Toxicology
Description

Laboratory tests in blood, urine, and tissue to determine effects of environmental exposure on human health, covering ATSDR-listed chemicals including PFAS, pesticides, metals, and volatile organic compounds. Serves occupational health, research, and government clients.

6PFAS Human Blood Testing
CategoryEnvironmental and Occupational Toxicology
Description

Biomonitoring for PFAS (perfluoroalkyl substances) exposure in human blood serum, with panels including PFAS compounds prevalent in industrial applications and AFFF. Pioneered since 2001 for leading chemical producers and expanded to broader biomonitoring.

7Forensic Drug Chemistry
CategoryForensic Drug Chemistry
Description

Identification and quantification of controlled substances, pharmaceutical preparations, and unknown substances including narcotics, cannabis, depressants, hallucinogens, and stimulants. Served from five laboratory locations with approximately 30-day average turnaround times.

8Newborn Toxicology (Umbilical Cord Testing)
CategoryClinical Toxicology
Description

Drug testing using umbilical cord tissue for detecting maternal drug exposure, offering comprehensive panels covering 16 major drug classes with 57 drugs and metabolites. Used by hospitals for newborn toxicology screening.

9Novel Psychoactive Substances (NPS) Testing
CategoryClinical and Forensic Toxicology
Description

Testing for designer drugs including fentanyl analogues, designer benzodiazepines, synthetic cannabinoids, bath salts, stimulants, and hallucinogens. Used by law enforcement, medical examiners, hospitals, and correctional facilities for emerging substance detection.

10Pharmaceutical Testing
CategoryPharmaceutical and Bioanalytical Testing
Description

FDA-registered pharmaceutical testing laboratory services including analytical method development, abuse deterrent formulations, biopharmaceutical applications, and stability studies. Serves pharmaceutical companies, CROs, and medical device manufacturers.

11Postmortem Toxicology
CategoryPostmortem Toxicology
Description

Forensic toxicology testing for medical examiners and coroners with three tiers: Basic (8051), Expanded (8052), and NMS TotalTox (8054) panels for autopsy specimen analysis. Used by medical examiners, coroners, and death investigators.

12THC Differentiation / Hemp-Marijuana Testing
CategoryForensic Drug Chemistry
Description

GC/MS with derivatization testing to differentiate hemp from marijuana and quantify THC concentration, CBD, THCA, and other cannabinoids in plant material, liquids, oils, edibles, and vape products. Used by crime laboratories and law enforcement.

13Therapeutic Drug Monitoring
CategoryClinical Toxicology
Description

Assays to assist physicians in assessing and adjusting patient medication doses for anticonvulsants, antidepressants, antipsychotics, antifungals, and other therapeutic drug classes. Serves hospitals and clinical providers.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Center for Forensic Science Research and Education (CFSRE)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-13
Description

NMS Labs works exclusively with the Center for Forensic Science Research and Education (CFSRE) to identify novel synthetic opioids and emerging drugs. CFSRE is continuously monitoring and updating testing panels to include the most prevalent, newly emerging drugs. The partnership supports public health surveillance and drug trend monitoring through the NPS Discovery initiative.

nmslabs.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2009-01-01
Description

Since 2009, NMS Labs has collaborated with the National Institute of Mental Health (NIMH) as well as various brain banks across the US for testing biological samples. This collaboration supports neuroscience research to understand causes and potential treatment for brain disorders and diseases.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Nashville-based forensic and clinical toxicology laboratory offering drugs-of-abuse, pain management, and forensic testing services to healthcare providers, employers, and the criminal justice system - highly comparable to NMS Labs' core toxicology offering and customer mix.

TypeDirect peer
Description

Specialized toxicology and drug-testing laboratory serving criminal justice, behavioral health, and clinical markets; directly comparable in forensic toxicology, chain-of-custody workflows, and court-defensible reporting used by NMS.

3United States Drug Testing Laboratories (USDTL)
TypeDirect peer
Description

Specialist drugs-of-abuse and toxicology reference laboratory providing forensic, clinical, and newborn toxicology testing - closely comparable to NMS Labs' esoteric testing menu and federal/state contracts.

TypeDirect peer
Description

Automated high-volume drugs-of-abuse testing laboratory serving workplace, clinical, and criminal justice customers; comparable to NMS in toxicology focus though more oriented toward routine high-throughput screening.

5Psychemedics Corporation
TypeDirect peer
Description

Specialist laboratory for hair-based drug testing serving employers, courts, and clinicians; overlaps with NMS Labs in forensic toxicology but uses a different specimen matrix.

TypeBroad incumbent
Description

National clinical laboratory with a substantial forensic toxicology and employer drug-testing business; offers overlapping capabilities to NMS but as part of a much broader routine diagnostic portfolio, not a specialty toxicology focus.

TypeBroad incumbent
Description

Large national reference laboratory with toxicology and workplace drug-testing offerings under its Diagnostics and Drug Development verticals; broad incumbent in NMS's clinical toxicology adjacency.

TypeBroad incumbent
Description

University-affiliated esoteric reference laboratory providing clinical and toxicology testing nationally; comparable as a reference/esoteric lab serving hospitals, though broader in scope than NMS's forensic specialty.

TypeBroad incumbent
Description

Reference laboratory offering esoteric testing including toxicology and bioanalytical services; comparable as a reference lab serving hospitals and health systems but with much broader scope than NMS's toxicology focus.

TypeRegional player
Description

Specialized drug-testing laboratory serving workplace, legal, and personal-health-testing customers primarily from a single US facility; comparable in toxicology focus but smaller scale and regionally concentrated relative to NMS's five-lab footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment12 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance11 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NMS Labs

Forensic and Clinical Toxicology Laboratory Servicesnmslabs.com

NMS Labs is a privately-held bioanalytical toxicology laboratory offering over 2,500 esoteric toxicology tests — including postmortem, DUID, NPS, PFAS, and pharmaceutical testing — to law enforcement, medical examiners, hospitals, crime labs, CROs, and research institutions across five US laboratory locations.

What NMS Labs does

NMS Labs is a privately-held bioanalytical toxicology laboratory headquartered in Horsham, Pennsylvania, founded around 1975 and operating for over 50 years. The company provides routine and esoteric toxicology testing services to law enforcement agencies, hospitals, medical examiners and coroners, crime laboratories, attorneys, correctional facilities, contract research organizations, and academic research institutions across the United States. Its service portfolio spans drug-impaired driving (DUID) toxicology, postmortem toxicology, drugs-of-abuse screening, novel psychoactive substances (NPS) testing, newborn umbilical cord tissue toxicology, exposure monitoring including PFAS biomonitoring, forensic drug chemistry, hemp/marijuana differentiation, therapeutic drug monitoring, and pharmaceutical testing.

The company's analytical platform is built on advanced mass spectrometry instrumentation — including GC/MS with derivatization, LC-MS/MS, ICP/MS, time-of-flight mass spectrometry, and proprietary immunoassays — supported by over 60 board-certified toxicologists and a continuously updated catalog of 2,500+ esoteric tests. Differentiated capabilities include the Comprehensive Umbilical Cord Drug Panel, hemp/marijuana differentiation methods recognized by the Texas Forensic Science Commission, dynamically updated NPS panels developed through the CFSRE partnership, and PFAS biomonitoring dating back to 2001. The lab holds a dense stack of accreditations (ABFT, ANAB ISO/IEC 17025, CAP ISO 15189, CLIA, FDA, DEA) and licenses across more than 15 state health departments.

NMS Labs generates revenue on a fee-for-service professional services model with monthly billing under net-30 terms for established accounts and pre-payment requirements for new or non-established accounts. Services are not offered directly to consumers — samples must be submitted by authorized professionals. Distribution is primarily through direct sales via dedicated phone/email lines by segment (Clinical & Research, Forensic, Expert Services, Crime Labs, Pharmaceutical Testing), supported by a client portal, an online test catalog of 2,500+ tests, and five physical laboratory locations across Pennsylvania, Texas, and North Carolina. The company also monetizes adjacent expertise through expert witness testimony, litigation support, and educational content development.

NMS Labs firmographics

Firmographics
Name
NMS Labs
Legal name
NMS Labs
Website
https://nmslabs.com
Company type
Private
Founded year
1975
Operating status
Operating
Headcount range
251–500 employees
Short description
NMS Labs is a privately-held bioanalytical toxicology laboratory offering over 2,500 esoteric toxicology tests — including postmortem, DUID, NPS, PFAS, and pharmaceutical testing — to law enforcement, medical examiners, hospitals, crime labs, CROs, and research institutions across five US laboratory locations.
Ownership category
akta.pro rank

NMS Labs industry classification

Industry
Product category
Forensic and Clinical Toxicology Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
akta.pro primary industry
Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)
akta.pro secondary industries
Reference & Esoteric Testing Laboratories (HLAFAMAJ), Bioanalytical & PK/PD Sample Analysis (Trial Support) (HLAGAEAG), Bioanalytical Testing (PK/ADA/NAb) (HLAGADAA)

Keywords

  • Forensic toxicology testing
  • Clinical toxicology services
  • Postmortem toxicology analysis
  • Drug chemistry testing
  • Pharmaceutical laboratory services

Where NMS Labs is headquartered

Location

Headquarters

HQ city
Horsham
HQ country
United States
HQ region
North America

Offices7 records

Markets served

NMS Labs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Laboratory Testing Services: NMS Labs generates revenue through providing comprehensive toxicology and drug identification testing services to various customers including law enforcement agencies, hospitals, medical examiners, crime laboratories, attorneys, correctional facilities, contract research organizations, and government agencies. Services include forensic toxicology, clinical toxicology, drug chemistry, exposure monitoring, pharmaceutical testing, and expert witness testimony. Billing is conducted through established accounts billed monthly with net-30 terms, and pre-payment is required for non-established accounts or patient/party responsibility payments.

Pricing tiers

ModelBillingPrice
OtherMonthlyLaboratory Testing Services

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

NMS Labs product offering

Product offering

Core offering

NMS Labs is a bioanalytical toxicology laboratory providing expansive routine and esoteric toxicology testing services to clinical, forensic, pharmaceutical, and research clients. Core offerings include forensic toxicology (postmortem, DUID, drug chemistry), clinical toxicology (drugs of abuse, therapeutic monitoring, newborn toxicology), exposure monitoring (PFAS biomonitoring), novel psychoactive substance testing, and pharmaceutical laboratory services. Supporting the testing services are expert witness consultation, expert testimony, and a client portal for sample submission and report retrieval.

Product overview

NMS Labs is a toxicology laboratory offering a comprehensive portfolio of testing services rather than a single unified product. The core offerings include Drug Impaired Driving (DUID) Testing, Drugs of Abuse Testing, Postmortem Toxicology (with Basic, Expanded, and NMS TotalTox panel tiers), Novel Psychoactive Substances (NPS) Testing, Drug Facilitated Crime Panel, Exposure Monitoring (including PFAS Human Blood Testing), Forensic Drug Chemistry, Newborn Toxicology using Umbilical Cord Tissue, Pharmaceutical Testing, THC/Hemp-Marijuana Differentiation, and Therapeutic Drug Monitoring. Supporting services include Expert Services (expert witness testimony and litigation support), Client Portal for online access, and specialized offerings like Wasp Dope Testing for correctional facilities. The company serves diverse segments including law enforcement, medical examiners, hospitals, crime laboratories, attorneys, researchers, and correctional facilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • Drug Impaired Driving (DUID) Testing Toxicology testing services for drug-impaired driving cases, covering alcohol, illicit drugs, OTC drugs, prescription drugs, Delta-8/Delta-9 THC, and Novel Psychoactive Substances with chain of custody and litigation support. Targeted at law enforcement agencies and the criminal justice system.
  • Drug Facilitated Crime Panel Single panel testing for substances specific to drug-facilitated crime investigations, covering nearly 100 analytes including the most frequently detected substances in DFC cases. Used by law enforcement and attorneys handling drug-facilitated crime cases.
  • Drugs of Abuse Testing Comprehensive testing for drugs of abuse including designer opioids, synthetic cannabinoids, bath salts, fentanyl analogues, hallucinogens, GHB, and prescription/OTC medications. Serves hospitals, correctional facilities, and law enforcement agencies.
  • Expert Services Board-certified toxicologist consultation, expert witness testimony, affidavit preparation, litigation packages, and pre-trial services for medico-legal investigations. Supports attorneys, law enforcement, and medico-legal stakeholders.
  • Exposure Monitoring Laboratory tests in blood, urine, and tissue to determine effects of environmental exposure on human health, covering ATSDR-listed chemicals including PFAS, pesticides, metals, and volatile organic compounds. Serves occupational health, research, and government clients.
  • PFAS Human Blood Testing Biomonitoring for PFAS (perfluoroalkyl substances) exposure in human blood serum, with panels including PFAS compounds prevalent in industrial applications and AFFF. Pioneered since 2001 for leading chemical producers and expanded to broader biomonitoring.
  • Forensic Drug Chemistry Identification and quantification of controlled substances, pharmaceutical preparations, and unknown substances including narcotics, cannabis, depressants, hallucinogens, and stimulants. Served from five laboratory locations with approximately 30-day average turnaround times.
  • Newborn Toxicology (Umbilical Cord Testing) Drug testing using umbilical cord tissue for detecting maternal drug exposure, offering comprehensive panels covering 16 major drug classes with 57 drugs and metabolites. Used by hospitals for newborn toxicology screening.
  • Novel Psychoactive Substances (NPS) Testing Testing for designer drugs including fentanyl analogues, designer benzodiazepines, synthetic cannabinoids, bath salts, stimulants, and hallucinogens. Used by law enforcement, medical examiners, hospitals, and correctional facilities for emerging substance detection.
  • Pharmaceutical Testing FDA-registered pharmaceutical testing laboratory services including analytical method development, abuse deterrent formulations, biopharmaceutical applications, and stability studies. Serves pharmaceutical companies, CROs, and medical device manufacturers.
  • Postmortem Toxicology Forensic toxicology testing for medical examiners and coroners with three tiers: Basic (8051), Expanded (8052), and NMS TotalTox (8054) panels for autopsy specimen analysis. Used by medical examiners, coroners, and death investigators.
  • THC Differentiation / Hemp-Marijuana Testing GC/MS with derivatization testing to differentiate hemp from marijuana and quantify THC concentration, CBD, THCA, and other cannabinoids in plant material, liquids, oils, edibles, and vape products. Used by crime laboratories and law enforcement.
  • Therapeutic Drug Monitoring Assays to assist physicians in assessing and adjusting patient medication doses for anticonvulsants, antidepressants, antipsychotics, antifungals, and other therapeutic drug classes. Serves hospitals and clinical providers.

Quantifiable outcome

  • 98.8% PFAS detection rate in human blood samples tested (10,566 samples)
  • +2 more outcomes

Companies that use NMS Labs

Customer profile

Named customers10 records

Segments12 records

Ideal customer profiles5 records

NMS Labs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

NMS Labs partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Center for Forensic Science Research and Education (CFSRE)coreStrategic or Co-development Partner · 13 February 2026NMS Labs works exclusively with the Center for Forensic Science Research and Education (CFSRE) to identify novel synthetic opioids and emerging drugs. CFSRE is continuously monitoring and updating testing panels to include the most prevalent, newly emerging drugs. The partnership supports public health surveillance and drug trend monitoring through the NPS Discovery initiative.
  • National Institute of Mental Health (NIMH)coreStrategic or Co-development Partner · 1 January 2009Since 2009, NMS Labs has collaborated with the National Institute of Mental Health (NIMH) as well as various brain banks across the US for testing biological samples. This collaboration supports neuroscience research to understand causes and potential treatment for brain disorders and diseases.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

NMS Labs competitors and assessment

Company assessment

Direct peers

  • Aegis Sciences Corporation: Nashville-based forensic and clinical toxicology laboratory offering drugs-of-abuse, pain management, and forensic testing services to healthcare providers, employers, and the criminal justice system - highly comparable to NMS Labs' core toxicology offering and customer mix.
  • Cordant Health Solutions: Specialized toxicology and drug-testing laboratory serving criminal justice, behavioral health, and clinical markets; directly comparable in forensic toxicology, chain-of-custody workflows, and court-defensible reporting used by NMS.
  • United States Drug Testing Laboratories (USDTL): Specialist drugs-of-abuse and toxicology reference laboratory providing forensic, clinical, and newborn toxicology testing - closely comparable to NMS Labs' esoteric testing menu and federal/state contracts.
  • Redwood Toxicology Laboratory: Automated high-volume drugs-of-abuse testing laboratory serving workplace, clinical, and criminal justice customers; comparable to NMS in toxicology focus though more oriented toward routine high-throughput screening.
  • Psychemedics Corporation: Specialist laboratory for hair-based drug testing serving employers, courts, and clinicians; overlaps with NMS Labs in forensic toxicology but uses a different specimen matrix.

Broad incumbents

  • Quest Diagnostics: National clinical laboratory with a substantial forensic toxicology and employer drug-testing business; offers overlapping capabilities to NMS but as part of a much broader routine diagnostic portfolio, not a specialty toxicology focus.
  • Laboratory Corporation of America (LabCorp): Large national reference laboratory with toxicology and workplace drug-testing offerings under its Diagnostics and Drug Development verticals; broad incumbent in NMS's clinical toxicology adjacency.
  • ARUP Laboratories: University-affiliated esoteric reference laboratory providing clinical and toxicology testing nationally; comparable as a reference/esoteric lab serving hospitals, though broader in scope than NMS's forensic specialty.
  • Mayo Clinic Laboratories: Reference laboratory offering esoteric testing including toxicology and bioanalytical services; comparable as a reference lab serving hospitals and health systems but with much broader scope than NMS's toxicology focus.

Regional players

  • Omega Laboratories: Specialized drug-testing laboratory serving workplace, legal, and personal-health-testing customers primarily from a single US facility; comparable in toxicology focus but smaller scale and regionally concentrated relative to NMS's five-lab footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

NMS Labs social profiles

Digital presence

NMS Labs compliance and trust

Trust signal

Compliance11 records

NMS Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NMS Labs leadership team

Management profile

Number of profiles

Profiles8 records

NMS Labs funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NMS Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NMS Labs

What does NMS Labs do?

NMS Labs is a bioanalytical toxicology laboratory providing expansive routine and esoteric toxicology testing services to clinical, forensic, pharmaceutical, and research clients. Core offerings include forensic toxicology (postmortem, DUID, drug chemistry), clinical toxicology (drugs of abuse, therapeutic monitoring, newborn toxicology), exposure monitoring (PFAS biomonitoring), novel psychoactive substance testing, and pharmaceutical laboratory services. Supporting the testing services are expert witness consultation, expert testimony, and a client portal for sample submission and report retrieval.

Is NMS Labs a public or private company?

NMS Labs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was NMS Labs founded?

NMS Labs was founded in 1975. It employs 251 to 500 people.

Where is NMS Labs based?

NMS Labs is headquartered in Horsham, United States, in the North America region.

How does NMS Labs make money?

One revenue line is on record: laboratory Testing Services.

Who are NMS Labs's main competitors?

Direct peers on record are Aegis Sciences Corporation, Cordant Health Solutions, United States Drug Testing Laboratories (USDTL), Redwood Toxicology Laboratory and Psychemedics Corporation. Broad incumbents are Quest Diagnostics, Laboratory Corporation of America (LabCorp), ARUP Laboratories and Mayo Clinic Laboratories. Omega Laboratories is listed as a regional player.

Does NMS Labs have an API?

No public API is recorded for NMS Labs.

What industry is NMS Labs in?

NMS Labs's product category is Forensic and Clinical Toxicology Laboratory Services. Its primary akta.pro industry code is HLAFAMAF, Toxicology & Therapeutic Drug Monitoring Laboratories, with a secondary code of HLAFAMAJ, Reference & Esoteric Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AijournNMS Labs Announces Promotion of Gregory Schuh as Chief Financial OfficerNMS Labs, a national leader in forensic and clinical toxicology services, announced the promotion of Gregory Schuh to Chief Financial Officer, effective July 21, 2026. Schuh joined the company in April 2023 as Controller and has since led finance and procurement automation initiatives and modernized internal business reporting. The promotion reflects NMS Labs' continued investment in operational excellence and financial stewardship, according to CEO Dave Delia.FinancialContent Business PageNMS Labs Announces Promotion of Gregory Schuh as Chief Financial OfficerNMS Labs announced the promotion of Gregory Schuh to Chief Financial Officer, effective July 21, 2026. Schuh joined the company in April 2023 as Controller and has since led finance and procurement automation initiatives while modernizing internal business reporting structures. He brings more than 20 years of financial leadership experience from the financial services and financial technology sectors.MorningstarNMS Labs Announces Promotion of Gregory Schuh as Chief Financial OfficerNMS Labs promoted Gregory Schuh to Chief Financial Officer, effective July 21, 2026. He joined as Controller in April 2023 and led finance and procurement automation initiatives. The promotion reflects the company's investment in operational excellence and commercial growth.Gadgets 360'Forever Chemicals' Detected In 98.8% Of Human Blood, What It Means For YouResearchers from NMS Labs in Pennsylvania tested 10,566 human blood samples and detected 'forever chemicals' (PFAS) in 98.8% of them, with most samples containing a mix of five or more different PFAS chemicals out of the 13 common types checked. The study found more than 70 different chemical combinations, with PFHxS—the chemical used in textiles, furniture, and glue—present in 97.9% of samples. While animal and cell studies have linked PFAS to health concerns including faster ageing, brain changes, and higher cancer risk, scientists have not yet proven a direct causal link in humans.ScienceAlert'Forever Chemicals' Found in 98.8% of Human Blood Samples TestedNMS Labs, a toxicology laboratory in Pennsylvania, tested 10,566 blood samples and found that 98.8 percent contained detectable levels of at least one type of PFAS (perfluoroalkyl and polyfluoroalkyl substances), with most samples containing complex mixtures of multiple PFAS chemicals and over 70 unique combinations identified. The researchers tested for 13 of the most common PFAS and found that substances like perfluorohexane sulfonic acid (PFHxS) appeared in 97.9 percent of samples, though the study only detected presence rather than measuring actual exposure levels. The study's authors emphasize the importance of mixture-based interpretation in biomonitoring given the widespread nature of PFAS exposure in the population.PR NewswireNovel study reveals that a surprising number of pregnant people are using cannabis -- and need to be informed of its risksResearch from NMS Labs analyzed 90,384 umbilical cord samples submitted during 2019-2023 and found 44% were positive for at least one analyte, with cannabinoids accounting for 59%-63% of all positive results—making cannabis the most common drug detected in utero, far higher than previously estimated. A separate study by researchers from the University of Louisville and ARUP Institute for Clinical and Experimental Pathology developed machine learning models (FFTree and xgBoost) that can predict post-surgical hydrocodone use duration with sensitivity ranging from 0.80 to 0.87, potentially helping clinicians identify patients at risk of prolonged opioid use. Both studies are being presented at ADLM 2024 (formerly the AACC Annual Scientific Meeting) in Chicago.PatchState-Of-The-Art Diagnostics Center Opening In HorshamThe Center for Diagnostic Discovery, a 50,000-square-foot facility located within NMS Labs' headquarters in Horsham Township, Pennsylvania, is set to open its first tenant in December. The center serves as an incubator for the diagnostics industry and will be anchored by The Center for Forensic Science Research & Education.PR NewswireExperts to Discuss the Essential Efforts of Clinical Laboratories to Fight the Opioid Epidemic at the 2020 AACC Annual Scientific MeetingExperts from NMS Labs and academic institutions will present research on advanced clinical laboratory testing methods to combat the opioid epidemic at the 2020 AACC Annual Scientific Meeting. The sessions highlight the limitations of standard immunoassays for detecting synthetic opioids like fentanyl and emphasize the need for partnerships between laboratories and federal agencies. Additionally, new studies regarding urine tests for fentanyl analogs and prescription drug interactions will be presented.PR NewswireNMS Labs and PinneyAssociates Announce Collaborative Agreement to Provide In Vitro Abuse-Deterrent Assessment ServicesNMS Labs and PinneyAssociates established a collaborative agreement in January 2019 to provide comprehensive in vitro abuse-deterrent assessment services for pharmaceutical companies developing central nervous system drugs. The partnership combines PinneyAssociates' regulatory expertise and FDA interaction experience with NMS Labs' laboratory testing capabilities established since 2002. The combined service offering aims to deliver comprehensive world-class testing of abuse-deterrent drug formulations for FDA submission.